BRIEF-Cellipont Bioservices And Ernexa Therapeutics Enter Cell Therapy Manufacturing Partnership To Advance Erna-101 Toward Clinical Trials In Ovarian Cancer

Reuters
Oct 29
BRIEF-Cellipont Bioservices And Ernexa <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Enter Cell Therapy Manufacturing Partnership To Advance Erna-101 Toward Clinical Trials In Ovarian Cancer

Ernexa Therapeutics Inc ERNA.O:

  • CELLIPONT BIOSERVICES AND ERNEXA THERAPEUTICS ENTER CELL THERAPY MANUFACTURING PARTNERSHIP TO ADVANCE ERNA-101 TOWARD CLINICAL TRIALS IN OVARIAN CANCER

Source text: ID:nPn4SGr2Sa

Further company coverage: ERNA.O

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10